-
Read more: DDR Holdings, LLC v. Priceline.com LLC
The omission of a word that was present in a provisional application may be used to inform claim construction of the claim terms of the nonprovisional patent, even if the provisional application was incorporated by reference in the nonprovisional patent.
-
Read more: Galderma Laboratories, L.P. v. Lupin Inc.
Bioequivalence is not sufficient, on its own, to prove infringement by the doctrine of equivalents by the function-way-result test. Bioequivalence may satisfy the result prong, but an accuser still must prove the accused product performs the same function and works in a similar way as the claimed invention.
-
Read more: PS Products Inc. v. Panther Trading Co. Inc.
A district court may impose additional sanctions under its inherent power on top of awarding attorney fees and costs under Section 285.
-
Read more: Cytiva Bioprocess R&D AB v. JSR Corp.
If a property of a claimed composition is inherent, then there is no requirement to show a reasonable expectation of success of achieving the claimed composition when combining prior art references to prove obviousness.
-
Read more: Mirror Worlds Technologies, LLC v. Meta Platforms, Inc.
Expert opinions that are based on unsupported evidence are not sufficient to create a dispute of material fact in order to overcome summary judgment.
-
Read more: Cisco Systems, Inc. v. K.Mizra LLC
A motion to dismiss an appeal after the court has already issued a decision is often improper, even when the parties have not made a request to vacate the opinion.
-
Read more: NexStep, Inc. v. Comcast Cable Communications, LLC
Proving infringement by the doctrine of equivalents requires particularized evidence that comes from the perspective of a person skilled in the art. This standard does not change based on the complexity of the claimed technology.
Want updates when we have new case summaries? Enter your email below to subscribe!